Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG245174 Inhibitors

EG245174 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of the **EG245174** protein, a molecular component likely involved in essential cellular processes such as signal transduction, enzymatic regulation, or molecular transport. These inhibitors bind to specific regions of the EG245174 protein, preventing it from interacting with its usual substrates or partners, thereby disrupting its activity within the cell. This inhibition allows researchers to study the downstream effects of blocking EG245174 on various biological pathways, providing insights into the molecular roles it plays in processes like cellular communication, energy metabolism, or protein synthesis. By inhibiting EG245174, scientists can explore how the protein contributes to the overall maintenance of cellular function and how its disruption affects molecular balance and network stability.

Research utilizing EG245174 inhibitors is critical for understanding the broader biological implications of this protein's activity. Blocking EG245174 enables scientists to observe the compensatory mechanisms or alternative pathways that may be activated in response to its absence, revealing how cells adapt to changes in key regulatory proteins. This research helps delineate the role of EG245174 in complex molecular networks and can highlight its involvement in critical intracellular interactions. By studying the effects of EG245174 inhibition, researchers gain a more detailed understanding of how this protein integrates into broader cellular processes, offering valuable insights into how cells regulate vital functions such as metabolic pathways, structural integrity, and signal transduction. Ultimately, EG245174 inhibitors serve as essential tools for uncovering the precise role of this protein in maintaining cellular homeostasis and understanding its molecular impact.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D, an RNA polymerase inhibitor, directly targets Zfp937 by interfering with RNA polymerase II activity. This inhibition disrupts Zfp937's DNA-binding transcription factor function, preventing its interaction with cis-regulatory regions and impeding the regulation of transcription by RNA polymerase II.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin, a potent RNA polymerase II inhibitor, directly inhibits Zfp937 by blocking transcription. This compound prevents Zfp937 from exerting its DNA-binding transcription factor activity, hindering its role in the regulation of transcription by RNA polymerase II.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Flavopiridol, a CDK (cyclin-dependent kinase) inhibitor, indirectly influences Zfp937 by modulating the cell cycle. By inhibiting CDKs, Flavopiridol may impact Zfp937's DNA-binding transcription factor activity, disrupting its involvement in the regulation of transcription by RNA polymerase II.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide, an RNA polymerase II inhibitor, directly targets Zfp937 by inhibiting transcription. This compound interferes with Zfp937's DNA-binding transcription factor activity, preventing its interaction with cis-regulatory regions and disrupting the regulation of transcription by RNA polymerase II.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB, an RNA synthesis inhibitor, directly targets Zfp937 by impeding RNA polymerase II activity. This compound disrupts Zfp937's DNA-binding transcription factor function, preventing its interaction with cis-regulatory regions and hindering the regulation of transcription by RNA polymerase II.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin, a topoisomerase I inhibitor, indirectly affects Zfp937 by modulating DNA topology. By inhibiting topoisomerase I, Camptothecin may impact Zfp937's DNA-binding transcription factor activity, potentially disrupting its role in the regulation of transcription by RNA polymerase II.